Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: Baseline results from the TWiTCH trial

American Journal of Hematology

Volumn 90, Issue 9, 2015, Pages 806-810

  Wood, John C ^a   Pressel, Sara ^b   Rogers, Zora R ^c   Odame, Isaac ^d   Kwiatkowski, Janet L ^e   Lee, Margaret T ^f   Owen, William C ^g   Cohen, Alan R ^h   St Pierre, Timothy ^h   Heeney, Matthew M ⁱ   Schultz, William H ^j   Davis, Barry R ^b   Ware, Russell E ^j  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

^j CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; IRON; ANTISICKLING AGENT; BENZOIC ACID DERIVATIVE; DEFERASIROX; DEFEROXAMINE; IRON CHELATING AGENT; TRIAZOLE DERIVATIVE;

ARTICLE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORE LABORATORY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; LIVER IRON CONCENTRATION; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; ADOLESCENT; ADVERSE EFFECTS; ANEMIA, SICKLE CELL; BIOASSAY; CHEMISTRY; CHILD; CLINICAL TRIAL; IRON OVERLOAD; LIVER; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; STANDARDS; STROKE;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BENZOATES; BIOLOGICAL ASSAY; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; DEFEROXAMINE; FEMALE; HUMANS; HYDROXYUREA; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; STROKE; TRIAZOLES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84939478700     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24089     Document Type: Article

References (31)

1. Ohene-Frempong K, Weiner, SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-294.
2. Scantlebury N, Mabbott, D, Janzen L, et al. White matter integrity and core cognitive function in children diagnosed with sickle cell disease. J Pediatr Hematol Oncol 2011;33:163-171.
3. Steen RG, Miles, MA, Helton KJ, et al. Cognitive impairment in children with hemoglobin SS sickle cell disease: Relationship to MR imaging findings and hematocrit. AJNR Am J Neuroradiol 2003;24:382-389.
4. Bernaudin F, Verlhac, S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 2011;117:1130-1140; quiz 1436.
5. Enninful-Eghan H, Moore, RH, Ichord R, et al. Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. J Pediatr 2010;157:479-484.
6. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol 2001;38:14-22.
7. Karam LB, Disco, D, Jackson SM, et al. Liver biopsy results in patients with sickle cell disease on chronic transfusions: Poor correlation with ferritin levels. Pediatr Blood Cancer 2008;50:62-65.
8. Angelucci E, Brittenham, GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. New Engl J Med 2000;343:327-331.
9. Aygun B, Mortier, N, Kesler K, et al. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload. Br J Haematol 2015; 169:262-266.
10. Kwiatkowski JL, Kim, HY, Thompson AA, et al. Chelation use and iron burden in North American and British thalassemia patients: A report from the Thalassemia Longitudinal Cohort. Blood 2012;119:2746-2753.
11. Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 2007;14:183-190.
12. St Pierre TG, El-Beshlawy, A, Elalfy M, et al. Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. Magn Reson Med 2014;71:2215-2223.
13. St Pierre TG, Clark, PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855-861.
14. St Pierre TG, Clark PR, Chua-Anusorn W. Single spin-echo proton transverse relaxometry of iron-loaded liver. NMR Biomed 2004;17:446-458.
15. Clark PR, Chua-anusorn W, St Pierre TG. Bi-exponential proton transverse relaxation rate (R2) image analysis using RF field intensity-weighted spin density projection: Potential for R2 measurement of iron-loaded liver. Magn Reson Imaging 2003;21:519-530.
16. Wood JC, Enriquez, C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460-1465.
17. Meloni A, Zmyewski, H, Rienhoff HYJ, et al. Fast approximation to pixelwise relaxivity maps: Validation in iron overloaded subjects. Magn Reson Imaging 2013;31:1074-1080.
18. Ghugre NR, Enriquez CM, Coates TD, et al. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9-16.
19. Hankins JS, McCarville, MB, Loeffler RB, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood 2009;113:4853-4855.
20. Fung EB, Harmatz, PR, Lee PD, et al. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease. Br J Haematol 2006;135:574-582.
21. Jenkins ZA, Hagar, W, Bowlus CL, et al. Iron homeostasis during transfusional iron overload in beta-thalassemia and sickle cell disease: changes in iron regulatory protein, hepcidin, and ferritin expression. Pediatr Hematol Oncol 2007;24:237-243.
22. Butensky E, Fischer, R, Hudes M, et al. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol 2005;123:146-152.
23. Garbowski MW, Carpenter, JP, Smith G, et al. Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J Cardiovasc Magn Reson 2014;16:40.
24. Wood JC, Zhang, P, Rienhoff H, et al. R2 and R2* are equally effective in evaluating chronic response to iron chelation. Am J Hematol 2014;89:505-508.
25. Ghugre NR, Wood JC. Relaxivity-iron calibration in hepatic iron overload: Probing underlying biophysical mechanisms using a Monte Carlo model. Magn Reson Med 2011;65:837-847.
26. Meloni A, Tyszka, JM, Pepe A, et al. Effect of inversion recovery fat suppression on hepatic r2* quantitation in transfusional siderosis. AJR Am J Roentgenol 2015;204:625-629.
27. He T, Gatehouse, PD, Kirk P, et al. Myocardial T(*)2 measurement in iron-overloaded thalassemia: An ex vivo study to investigate optimal methods of quantification. Magn Reson Med 2008;60:350-356.
28. Westwood MA, Anderson, LJ, Firmin DN, et al. Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging 2003;18:616-620.
29. Westwood MA, Firmin, DN, Gildo M, et al. Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 2005;21:531-538.
30. Kirk P, He, T, Anderson LJ, et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging 2010;32:315-319.
31. Wood JC, Zhang, P, Rienhoff H, et al. Liver MRI is more precise than liver biopsy for assessing total body iron balance: A comparison of MRI relaxometry with simulated liver biopsy results. Magn Reson Imaging 2015; 33:761-767.